These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 24500704)
1. Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years. Kawai M; Malone KE; Tang MT; Li CI Cancer; 2014 May; 120(10):1548-56. PubMed ID: 24500704 [TBL] [Abstract][Full Text] [Related]
2. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer. Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749 [TBL] [Abstract][Full Text] [Related]
3. Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years. Kawai M; Malone KE; Tang MT; Li CI Cancer; 2014 Apr; 120(7):1026-34. PubMed ID: 24515648 [TBL] [Abstract][Full Text] [Related]
4. Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women. Chen L; Li CI; Tang MT; Porter P; Hill DA; Wiggins CL; Cook LS Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1297-304. PubMed ID: 27307466 [TBL] [Abstract][Full Text] [Related]
5. Relationship of established risk factors with breast cancer subtypes. McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510 [TBL] [Abstract][Full Text] [Related]
6. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. Ma H; Ursin G; Xu X; Lee E; Togawa K; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Lu Y; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L Breast Cancer Res; 2018 Jan; 20(1):5. PubMed ID: 29357906 [TBL] [Abstract][Full Text] [Related]
7. Association of breast cancer subtypes and body mass index. Petekkaya I; Sahin U; Gezgen G; Solak M; Yuce D; Dizdar O; Arslan C; Ayyildiz V; Altundag K Tumori; 2013; 99(2):129-33. PubMed ID: 23748802 [TBL] [Abstract][Full Text] [Related]
8. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. Yang XR; Chang-Claude J; Goode EL; Couch FJ; Nevanlinna H; Milne RL; Gaudet M; Schmidt MK; Broeks A; Cox A; Fasching PA; Hein R; Spurdle AB; Blows F; Driver K; Flesch-Janys D; Heinz J; Sinn P; Vrieling A; Heikkinen T; Aittomäki K; Heikkilä P; Blomqvist C; Lissowska J; Peplonska B; Chanock S; Figueroa J; Brinton L; Hall P; Czene K; Humphreys K; Darabi H; Liu J; Van 't Veer LJ; van Leeuwen FE; Andrulis IL; Glendon G; Knight JA; Mulligan AM; O'Malley FP; Weerasooriya N; John EM; Beckmann MW; Hartmann A; Weihbrecht SB; Wachter DL; Jud SM; Loehberg CR; Baglietto L; English DR; Giles GG; McLean CA; Severi G; Lambrechts D; Vandorpe T; Weltens C; Paridaens R; Smeets A; Neven P; Wildiers H; Wang X; Olson JE; Cafourek V; Fredericksen Z; Kosel M; Vachon C; Cramp HE; Connley D; Cross SS; Balasubramanian SP; Reed MW; Dörk T; Bremer M; Meyer A; Karstens JH; Ay A; Park-Simon TW; Hillemanns P; Arias Pérez JI; Menéndez Rodríguez P; Zamora P; Benítez J; Ko YD; Fischer HP; Hamann U; Pesch B; Brüning T; Justenhoven C; Brauch H; Eccles DM; Tapper WJ; Gerty SM; Sawyer EJ; Tomlinson IP; Jones A; Kerin M; Miller N; McInerney N; Anton-Culver H; Ziogas A; Shen CY; Hsiung CN; Wu PE; Yang SL; Yu JC; Chen ST; Hsu GC; Haiman CA; Henderson BE; Le Marchand L; Kolonel LN; Lindblom A; Margolin S; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Górski B; Gronwald J; Hooning MJ; Hollestelle A; van den Ouweland AM; Jager A; Kriege M; Tilanus-Linthorst MM; Collée M; Wang-Gohrke S; Pylkäs K; Jukkola-Vuorinen A; Mononen K; Grip M; Hirvikoski P; Winqvist R; Mannermaa A; Kosma VM; Kauppinen J; Kataja V; Auvinen P; Soini Y; Sironen R; Bojesen SE; Ørsted DD; Kaur-Knudsen D; Flyger H; Nordestgaard BG; Holland H; Chenevix-Trench G; Manoukian S; Barile M; Radice P; Hankinson SE; Hunter DJ; Tamimi R; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gaborieau V; Devilee P; Huijts PE; Tollenaar RA; Seynaeve C; Dite GS; Apicella C; Hopper JL; Hammet F; Tsimiklis H; Smith LD; Southey MC; Humphreys MK; Easton D; Pharoah P; Sherman ME; Garcia-Closas M J Natl Cancer Inst; 2011 Feb; 103(3):250-63. PubMed ID: 21191117 [TBL] [Abstract][Full Text] [Related]
9. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999 [TBL] [Abstract][Full Text] [Related]
10. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; O'Meara ES; Li CI Ann Epidemiol; 2012 May; 22(5):340-8. PubMed ID: 22366170 [TBL] [Abstract][Full Text] [Related]
11. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826 [TBL] [Abstract][Full Text] [Related]
12. The epidemiology of triple-negative breast cancer, including race. Trivers KF; Lund MJ; Porter PL; Liff JM; Flagg EW; Coates RJ; Eley JW Cancer Causes Control; 2009 Sep; 20(7):1071-82. PubMed ID: 19343511 [TBL] [Abstract][Full Text] [Related]
13. Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women. Horn J; Alsaker MD; Opdahl S; Engstrøm MJ; Tretli S; Haugen OA; Bofin AM; Vatten LJ; Asvold BO Int J Cancer; 2014 Dec; 135(11):2678-86. PubMed ID: 24752603 [TBL] [Abstract][Full Text] [Related]
14. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Xing P; Li J; Jin F Med Oncol; 2010 Sep; 27(3):926-31. PubMed ID: 19771534 [TBL] [Abstract][Full Text] [Related]
15. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium. Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132 [TBL] [Abstract][Full Text] [Related]
16. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290 [TBL] [Abstract][Full Text] [Related]
17. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Bao PP; Shu XO; Gao YT; Zheng Y; Cai H; Deming SL; Ruan ZX; Su Y; Gu K; Lu W; Zheng W Am J Epidemiol; 2011 Sep; 174(6):661-71. PubMed ID: 21768404 [TBL] [Abstract][Full Text] [Related]
18. Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium. Bandera EV; Chandran U; Hong CC; Troester MA; Bethea TN; Adams-Campbell LL; Haiman CA; Park SY; Olshan AF; Ambrosone CB; Palmer JR; Rosenberg L Breast Cancer Res Treat; 2015 Apr; 150(3):655-66. PubMed ID: 25809092 [TBL] [Abstract][Full Text] [Related]
19. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227 [TBL] [Abstract][Full Text] [Related]
20. Alcohol, smoking, and risk of Her2-overexpressing and triple-negative breast cancer relative to estrogen receptor-positive breast cancer. Baglia ML; Cook LS; Mei-Tzu C; Wiggins C; Hill D; Porter P; Li CI Int J Cancer; 2018 Oct; 143(8):1849-1857. PubMed ID: 29708591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]